OUCRU workshop bridges research and clinical practice on Pneumococcal infections 

On November 22, 2024, the Zoonoses research group at OUCRU, in collaboration with Children’s Hospital 2, Ho Chi Minh City, successfully organised a scientific workshop: “Community-acquired pneumonia: Update on pneumococcal infection with vaccines, drug resistance and multiple infections”.

The workshop attracted nearly 70 experts, including doctors, nurses, medical students, and technicians.

Researcher Explores End-of-Life Care in Vietnam

Luu Phuoc An, a PhD student at OUCRU, is dedicated to improving end-of-life care in Vietnam. Her research explores the complex cultural, emotional, and medical aspects of death and dying in hospital settings.

Tuberculosis in Ho Chi Minh City: Who’s at Risk? 

A recent study identified key factors contributing to the tuberculosis burden in Ho Chi Minh City. It was conducted by researchers from the University of Oxford, the Oxford University Clinical Research Unit in Vietnam (OUCRU), and Pham Ngoc Thach Hospital.

OUCRU 2024 Prize Studentship

2018_PhD Celebration_7814

Congratulations to the recipients of this year’s OUCRU-SOVICO Prize Studentships! These excellent candidates will join the OUCRU PhD family and enrol at the University of Oxford’s Nuffield Department of Medicine. Dr Tran Bang Huyen, supervised by Assoc Prof Sophie Yacoub, Head of Dengue Group at OUCRU. Ms Nguyen Pham Nhu Quynh, supervised by Dr Pham […]

2023 Three-Minute Thesis and MORU-OUCRU Student Conference

MORU and OUCRU unite annually to enhance postgraduate learning, improving academic ecosystems, fostering student-supervisor connections, excelling in mentorship, and championing effective science communication. Building on the success of previous years, we have once again organised the highly anticipated Three-Minute Thesis competition and the impactful MORU-OUCRU Student Conference.

New Study: Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults

VIETNAM, HO CHI MINH CITY – On 12 October 2023, the results of the ACT HIV trial – Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-positive Adults – were published in the New England Journal of Medicine. Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, kills around 1.5 million people each year. Tuberculous meningitis is the most […]

Skip to content